Evidence map›Paper›PMID 38852836›Full record

ArticleJournal of immunological methods2024

Antisera against flagellin A or B inhibits Pseudomonas aeruginosa motility as measured by novel video microscopy assay.

Ethel Apolinario, James Sinclair, Myeongjin Choi, Kun Luo, Surekha Shridhar, Sharon M Tennant, Raphael Simon, Erik Lillehoj, Alan Cross

Abstract read
In one paragraph

Article in Journal of immunological methods, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ethel ApolinarioUniversity of Maryland Baltimore, School of Medicine, Center for Vaccine Development & Global Health, Baltimore, MD, USA. Electronic address: eapolinario@som.umaryland.edu.
James SinclairUniversity of Maryland Baltimore, School of Medicine, Center for Vaccine Development & Global Health, Baltimore, MD, USA.
Myeongjin ChoiUniversity of Maryland Baltimore, School of Medicine, Center for Vaccine Development & Global Health, Baltimore, MD, USA; 141 Department of Advanced Toxicology Research, Korea Institute of Toxicology, Daejeon, Republic of Korea.
Kun LuoUniversity of Maryland Baltimore, School of Medicine, Center for Vaccine Development & Global Health, Baltimore, MD, USA; Miltenyi Biotec, Inc., 1201 Clopper Road, Gaithersburg, MD, USA.
Surekha ShridharUniversity of Maryland Baltimore, School of Medicine, Center for Vaccine Development & Global Health, Baltimore, MD, USA.
Sharon M TennantUniversity of Maryland Baltimore, School of Medicine, Center for Vaccine Development & Global Health, Baltimore, MD, USA.
Raphael SimonUniversity of Maryland Baltimore, School of Medicine, Center for Vaccine Development & Global Health, Baltimore, MD, USA; Pfizer, Saddle River, NJ, USA.
Erik LillehojUniversity of Maryland Baltimore, School of Medicine, Department of Pediatrics, Baltimore, MD, USA.
Alan CrossUniversity of Maryland Baltimore, School of Medicine, Center for Vaccine Development & Global Health, Baltimore, MD, USA.

Funding

Probiotic yeast secreting single-domain antibodies to prevent Clostridium difficile and Campylobacter jejuni diseaseU19AI142725 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2019 to 2023
$12.5M
NIAID NIH HHS U19 AI142725
6 · The paper itself

Abstract

Flagellum-mediated motility is essential to Pseudomonas aeruginosa (P. aeruginosa) virulence. Antibody against flagellin reduces motility and inhibits the spread of the bacteria from the infection site. The standard soft-agar assay to demonstrate anti-flagella motility inhibition requires long incubation times, is difficult to interpret, and requires large amounts of antibody. We have developed a time-lapse video microscopy method to analyze anti-flagellin P. aeruginosa motility inhibition that has several advantages over the soft agar assay. Antisera from mice immunized with flagellin type A or B were incubated with Green Fluorescent Protein (GFP)-expressing P. aeruginosa strain PAO1 (FlaB+) and GFP-expressing P. aeruginosa strain PAK (FlaA+). We analyzed the motion of the bacteria in video taken in ten second time intervals. An easily measurable decrease in bacterial locomotion was observed microscopically within minutes after the addition of small volumes of flagellin antiserum. From data analysis, we were able to quantify the efficacy of anti-flagellin antibodies in the test serum that decreased P. aeruginosa motility. This new video microscopy method to assess functional activity of anti-flagellin antibodies required less serum, less time, and had more robust and reproducible endpoints than the standard soft agar motility inhibition assay.

Indexed as

Antibodies, BacterialFlagellaFlagellinImmune SeraMicroscopy, VideoPseudomonas aeruginosaAnimalsMicePseudomonas InfectionsAntibodies, BacterialFlagellinImmune SeraFlaAFlaBFlagellinMotility inhibitionPseudomonas aeruginosaVideo microscopy assay

Identifiers

PMID38852836
PMCPMC11285035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.